MarketFriction

Choksi Asia Ltd

BSE 530427 · Medical Equipment & Supplies
₹205.05 +4.86%
BSE close2026-10-01
Market cap₹117 Cr.
P/E22.5

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.523.040.151.378.428.6712.1511.9013.2912.2611.869.22
Expenses1.153.230.561.097.458.9510.9110.5111.6910.479.867.84
Operating Profit-0.63-0.19-0.410.280.97-0.281.241.391.601.792.001.38
OPM %-121.15%-6.25%-273.33%20.44%11.52%-3.23%10.21%11.68%12.04%14.60%16.86%14.97%
Other Income0.200.470.250.190.240.820.230.290.290.520.310.29
Interest0.000.000.000.000.130.120.090.100.140.090.090.04
Depreciation0.040.050.040.040.040.050.040.060.080.050.070.09
Profit before tax-0.470.23-0.200.431.040.371.341.521.672.172.151.54
Tax %0.00%-173.91%-255.00%16.28%36.54%40.54%47.01%28.95%19.16%1.38%65.12%37.66%
Net Profit-0.470.630.310.360.650.220.711.071.352.130.750.96
EPS in Rs-1.211.620.790.921.670.561.821.882.373.741.321.68
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales45.9627.2623.0817.3316.0011.162.460.7715.9936.9849.3146.63
Expenses43.4026.3121.7717.7517.4212.853.922.2116.0133.1742.5239.86
Operating Profit2.560.951.31-0.42-1.42-1.69-1.46-1.44-0.023.816.796.77
OPM %5.57%3.48%5.68%-2.42%-8.88%-15.14%-59.35%-187.01%-0.13%10.30%13.77%14.52%
Other Income0.400.430.741.641.064.581.141.162.101.581.401.41
Interest0.370.000.000.000.000.000.000.000.400.480.420.36
Depreciation0.410.390.220.210.170.190.170.160.180.180.270.29
Profit before tax2.180.991.831.01-0.532.70-0.49-0.441.504.737.507.53
Tax %0.92%22.22%30.05%14.85%5.66%29.26%-12.24%6.82%7.33%34.25%28.93%
Net Profit2.170.771.290.86-0.561.91-0.42-0.481.393.105.335.19
EPS in Rs5.561.973.312.21-1.444.90-1.08-1.233.567.959.359.11
Dividend Payout %17.97%37.99%22.67%22.67%0.00%51.05%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth1%35%300%13%
Compounded Profit Growth9%23%136%96%
Stock Price CAGR22%38%62%150%
Return on Equity7%8%11%16%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital3.903.903.903.903.903.903.903.903.905.705.705.70
Reserves8.3110.0110.9911.9212.4211.6213.5312.0911.6222.3725.7931.02
Borrowings6.430.000.000.000.000.000.000.000.009.2110.167.31
Other Liabilities17.0922.4520.8020.8820.9120.083.792.422.534.515.533.40
Total Liabilities35.7336.3635.6936.7037.2335.6021.2218.4118.0541.7947.1847.43
Fixed Assets8.818.508.037.817.517.346.125.955.7914.9515.5816.39
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments0.003.877.495.362.936.870.783.350.000.000.000.00
Other Assets26.9223.9920.1723.5326.7921.3914.329.1112.2626.8431.6031.04
Total Assets35.7336.3635.6936.7037.2335.6021.2218.4118.0541.7947.1847.43
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity10.647.931.655.492.42-2.52-2.82-0.56-2.522.68-2.870.74
Cash from Investing Activity-0.12-0.17-0.010.000.58-0.011.96-2.493.351.520.630.20
Cash from Financing Activity-11.45-6.900.00-0.35-0.35-0.240.00-0.980.000.47-1.20-3.40
Net Cash Flow-0.940.861.655.142.64-2.77-0.85-4.020.834.67-3.43-2.46
Free Cash Flow10.527.761.645.493.00-2.53-0.86-0.56-2.522.79-3.69-0.35
CFO/OP578%308%174%422%-581%177%153%25%175%-13,400%-75%-9%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days32.7763.4578.86106.43103.41107.6832.7189.02180.1381.7282.2270.02
Inventory Days46.51101.48125.3789.13155.93112.8434.4771.321,971.00149.98106.2086.13
Days Payable53.76209.89350.06406.96502.85531.0744.8127.2787.6046.4939.4413.71
Cash Conversion Cycle25.52-44.96-145.82-211.39-243.51-310.5522.37133.082,063.53185.21148.99142.44
Working Capital Days4.05-12.31-74.85-114.50-139.43-178.1777.19381.322,360.65131.25138.28133.98
ROCE %6.00%15.67%6.53%9.64%5.66%-3.33%16.39%-2.93%-2.79%7.20%13.20%18.49%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters63.44%63.44%63.44%63.44%62.22%62.22%62.22%62.22%71.15%71.15%71.15%71.15%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%
Public36.55%36.55%36.55%36.56%37.77%37.78%37.77%37.78%28.85%28.84%28.85%28.67%
No. of Shareholders3,0293,0553,1003,0012,9763,2773,1893,1323,0873,0382,9822,960

Fundamentals

Market Cap₹ 117 Cr.
Current Price₹ 205
Stock P/E22.5
Book Value₹ 64.4
ROCE18.5 %
ROE15.6 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)13%
Compounded Profit Growth (TTM)96%
Standalone figures.
Valuation
Market capRs 117 Cr
Enterprise valueRs 118 Cr
P/E (TTM)22.52x
Price to book3.18x
Price to sales2.51x
EV / EBITDA14.38x
EV / EBIT14.91x
EV / sales2.52x
Price to cash flow157.97x
Earnings yield4.44%
P/E, 3-year average16.62x
P/B, 3-year average1.44x
P/E, 5-year average16.62x
P/B, 5-year average1.27x
Profitability
Operating margin (excl. other income)13.77%
Operating margin (incl. other income)16.61%
EBITDA margin17.54%
Pre-tax margin16.15%
Net profit margin11.13%
Net margin, latest quarter10.41%
ROE15.63%
ROCE18.49%
ROA11.27%
ROE, 3-year average10.81%
ROCE, 3-year average12.96%
ROA, 3-year average7.63%
ROE, 5-year average5.37%
ROCE, 5-year average6.63%
ROA, 5-year average3.63%
ROIC (approx.)14.97%
Tax rate28.93%
Other income / net worth3.81%
Growth
Sales growth (latest year)33.34%
Profit growth (latest year)71.94%
Sales CAGR, 3 years300.08%
Sales CAGR, 5 years34.60%
Profit CAGR, 5 years22.78%
Sales growth QoQ-22.26%
Profit growth QoQ28.00%
Sales growth YoY (latest quarter)-22.52%
Profit growth YoY (latest quarter)-10.28%
Per share
EPS (TTM)Rs 9.10
EPS (latest year)Rs 9.35
EPS (latest quarter)Rs 1.68
EPS, 3-year averageRs 5.74
EPS, 5-year averageRs 2.98
Book value per shareRs 64.41
Sales per shareRs 81.79
Cash flow per shareRs 1.30
Free cash flow per shareRs -0.61
Efficiency
Asset turnover1.04x
Fixed asset turnover3.01x
Inventory turnover4.26x
Inventory days86 days
Debtor days70 days
Debtors turnover5.21x
Creditor days14 days
Cash conversion cycle142 days
Working capital days134 days
Leverage
Total debtRs 7 Cr
Cash and bankRs 7 Cr
Net debtRs 1 Cr
Debt to equity0.20x
Net debt / EBITDA0.09x
Interest coverage21.92x
Owners' fund to total sources77.42%
Debt to assets15.41%
Cash flow
Cash from Operating Activity (latest year)Rs 1 Cr
Cash from Investing Activity (latest year)Rs 0 Cr
Cash from Financing Activity (latest year)Rs -3 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs -0 Cr
FCFE (approx.: FCF + change in debt)Rs -3 Cr
Cash from ops / profit, 5 years-0.28x
Sales to cash flow66.64x
Statement figures
Net sales (TTM)Rs 47 Cr
Net sales (latest year)Rs 49 Cr
Sales (latest quarter)Rs 9 Cr
Operating profit excl. other income (latest year)Rs 7 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 8 Cr
PBDT (TTM)Rs 8 Cr
Profit before tax (TTM)Rs 8 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 5 Cr
Net profit (latest year)Rs 5 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 39 Cr
Total expenditure (latest year)Rs 43 Cr
Total income (latest year)Rs 51 Cr
Share capitalRs 6 Cr
ReservesRs 31 Cr
Shareholders' fundsRs 37 Cr
Total assetsRs 47 Cr
Net blockRs 16 Cr
ReceivablesRs 9 Cr
InventoryRs 9 Cr
Other liabilitiesRs 3 Cr
Shares outstanding (crore)0.57
Ownership
Promoter holding71.15% (+8.93 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 22.5 is at the 70th percentile of its own 6.4-year range (median 16.1, low 6.0, high 37.5).
P/B 3.18 is at the 97th percentile (median 1.32).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period530427Nifty 50Difference
1 week-5.7%-2.8% -2.9 pts
1 month-15.6%-6.8% -8.8 pts
3 months+23.3%-7.6% +30.9 pts
3 years+329.4%+14.2% +315.2 pts
5 years+387.1%+27.9% +359.2 pts

Red flags

F-score 6 of 7
explainWeak cash conversion Cash from operations was 6% of net profit over the last 3 years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹9 Cr -22.5% vs Jun 2025. Net profit ₹1 Cr -10.3%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Poly Medicure Ltd16,67152.112.5 %
Molbio Diagnostics Ltd14,47066.618.0 %
Fischer Medical Ventures Ltd2,35596.211.4 %
Tarsons Products Ltd1,7541484.59 %
Q-Line Biotech Ltd1,56927.822.5 %
Laxmi Dental Ltd1,05830.415.0 %
Hemant Surgical Industries Ltd86951.318.9 %
Vasa Denticity Ltd75462.37.54 %
OSEL Devices Ltd69123.624.4 %
Prevest Denpro Ltd46220.524.9 %
QMS Medical Allied Services Ltd41939.012.9 %
Nureca Ltd34980.43.30 %
Aprameya Engineering Ltd20039.712.6 %
Avience Biomedicals Ltd19822.727.0 %
Earkart Limited17936.317.5 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Choksi Asia Ltd?

Choksi Asia Ltd (530427) has a market capitalisation of Rs 117 Cr. at the 2026-10-01 close.

What is the P/E ratio of Choksi Asia Ltd?

Choksi Asia Ltd trades at a P/E of 22.5 on trailing twelve-month profit, at the 2026-10-01 close.

What were Choksi Asia Ltd's latest quarterly results?

In the Jun 2026 quarter, Choksi Asia Ltd sales was Rs 9 Cr (-22.5% vs Jun 2025) and net profit was Rs 1 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03